XERS vs XNCR: stock comparison and AI forecast
Xeris Biopharma Holdings, Inc. (XERS) and Xencor Inc (XNCR) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
XERS Xeris Biopharma Holdings, Inc.
- Market Cap
- $2.38B
- P/E Ratio
- 218.0x
- Size
- mid-cap
- AI Forecast
XNCR Xencor Inc
- Market Cap
- $2.66B
- P/E Ratio
- –
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- XNCR is 1.1 times larger than XERS by market capitalization ($2.66B against $2.38B).
- XERS carries 7.68 times debt per unit of equity, against 0.37 times for XNCR.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | XERS | XNCR |
|---|---|---|
| Market Cap | $2.38B | $2.66B |
| P/E Ratio | 218.00x | – |
| P/B Ratio | 48.88x | 4.74x |
| EPS | $0.06 | $-2.24 |
| Book Value/Share | $0.27 | $7.54 |
| Revenue/Share | $2.02 | $1.95 |
| FCF/Share | – | $-2.37 |
Profitability & Margins
| Metric | XERS | XNCR |
|---|---|---|
| ROE | – | -21.0% |
| ROA | – | -15.3% |
| ROIC | 16.2% | -21.0% |
| Gross Margin | 87.4% | – |
| Operating Margin | 12.7% | -100.7% |
| Net Margin | – | -81.4% |
| EBT Margin | 2.5% | -79.8% |
| Tax Rate | 0.0% | -2.0% |
Financial Health
| Metric | XERS | XNCR |
|---|---|---|
| Current Ratio | 2.15x | 6.54x |
| Quick Ratio | 1.58x | – |
| D/E Ratio | 7.68x | 0.37x |
| Financial Leverage | 8.68x | 1.37x |
| Interest Coverage | 2.5x | -9267.0x |
| Working Capital | $155M | $422M |
Cash Flow
| Metric | XERS | XNCR |
|---|---|---|
| Operating Cash Flow | $74M | -$172M |
| Free Cash Flow | – | -$176M |
| Capital Spending | – | -$4M |
| OCF Growth YoY | 597.5% | – |
| FCF/Sales | – | -121.9% |
| CapEx/Sales | – | 2.8% |
Operational Efficiency
| Metric | XERS | XNCR |
|---|---|---|
| Asset Turnover | 0.87x | 0.19x |
| Receivables Turnover | 5.4x | 2.2x |
| Inventory Turnover | 0.6x | – |
| Fixed Assets Turnover | 79.4x | 2.9x |
| Days Sales Outstanding | 68 days | 163 days |
| Days Inventory | 604 days | – |
| Payables Period | 63 days | – |
| Cash Conversion Cycle | 609 days | – |
Income Statement
| Metric | XERS | XNCR |
|---|---|---|
| Total Revenue | $368M | $145M |
| Operating Income | $47M | -$146M |
| Net Income | – | -$118M |
| R&D Expense | $38M | $286M |
| SG&A Expense | $226M | – |
| Cost of Goods Sold | $46M | – |
Dividend & Shareholder Information
| Metric | XERS | XNCR |
|---|---|---|
| Shares Outstanding | 182M | 74M |
XERS vs XNCR: stock comparison and AI forecast
Which is bigger, XERS or XNCR?
XNCR is 1.1 times larger than XERS by market capitalization ($2.66B against $2.38B).
Which one does Intratio's AI model rank higher, XERS or XNCR?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.